IQVIA Holdings Aktie
196,52USD | 3,39USD | 1,76% |
WKN DE: A2JSPM / ISIN: US46266C1053
Personal
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 70 000 | 79 000 | 86 000 | 87 000 | 88 000 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,16 | 0,18 | 0,17 | 0,17 | 0,00 |
Bilanz (in Mio. USD) - Aktiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 5 090 | 4 763 | 4 981 | 5 596 | 5 829 |
Summe Anlagevermögen | 19 474 | 19 926 | 20 356 | 21 085 | 21 070 |
Summe Aktiva | 24 564 | 24 689 | 25 337 | 26 681 | 26 899 |
Bilanz (in Mio. USD) - Passiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Fremdkapital | 18 284 | 18 647 | 19 572 | 20 569 | 20 832 |
Summe Eigenkapital | 6 280 | 6 042 | 5 765 | 6 112 | 6 067 |
Summe Passiva | 24 564 | 24 689 | 25 337 | 26 681 | 26 899 |
Adresse
2400 Ellis Road, 27703 Durham | |
Telefon | +1 (919) 998-2000 |
Internet | http://www.iqvia.com |
Management
Ari Bousbib
Chairman, President & Chief Executive Officer |
Carol J. Burt
Independent Director |
Colleen A. Goggins
Independent Director |
Eric M. Sherbet
Secretary, Executive VP & General Counsel |
James A. Fasano
Independent Director |
James Grant Berkshire
Executive VP-Global Technology & Operations |
Jeffrey A. Spaeder
Chief Medical & Scientific Officer |
Joanne M. Hackett
Head-Genomic & Precision Medicine |
John G. Danhakl
Independent Director |
John M. Leonard
Lead Independent Director |
John P. Connaughton
Independent Director |
Karl Guenault
Chief Information Officer & Senior Vice President |
Keriann Cherofsky
Chief Accounting Officer, Senior VP & Controller |
Kerri Joseph
Senior VP-Investor Relations & Treasury |
Leslie Wims Morris
Independent Director |
Ronald Earl Bruehlman
Chief Financial Officer & Executive Vice President |
Sanjay Chikarmane
Chief Product Officer |
Sheila A. Stamps
Independent Director |
Todd Benjamin Sisitsky
Independent Director |
Trudy Stein
Chief Human Resources Officer & Executive VP |
W. Richard Staub
President-Research & Development Solutions |